{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:12:23Z","timestamp":1788480743849,"version":"build-2803163510"},"reference-count":57,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Suomen infektiol\u00e4\u00e4k\u00e4rit ry"},{"name":"Gilead Sciences"},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Patient Care and STDs"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:p>Previous studies have reported an increased risk of new cardiovascular events and differences in treatment after acute coronary syndrome (ACS) in people with HIV (PWH) compared with people without HIV (PWOH). Our aim was to compare the contemporary in-hospital treatment, lipid-lowering therapy and 1-year outcomes after ACS in PWH and PWOH in Finland. We collected data retrospectively from national registers and matched each PWH with ACS in 2017\u20132023 to PWOH 1:4 by age, sex, year, and area. The study included 35 PWH and 128 PWOH. Of them, 30 PWH (86%) and 119 PWOH (93%) underwent coronary angiography with no difference in invasive treatment after angiography [22\/28 PWH (79%) and 79\/103 PWOH (77%); those with zero occluded arteries excluded]. One-year mortality was comparable. PWH had more new cardiovascular events during follow-up [5 PWH (15%) vs. 13 PWOH (10%)] driven by elective revascularizations and recurrent ACS, but with no statistical evidence of a difference [HR 1.42 (95% CI: 0.50\u20133.98)]. Lipid-lowering therapy was prescribed to 18\/19 PWH (95%) and 74\/79 PWOH (94%), with &gt;80% of the medication high-intensity for both PWH and PWOH. All but two people purchased the medication after discharge, and 92% of the whole population at 6 to 12 months after the ACS. Still, only 37% of PWH and 30% of PWOH achieved low-density lipoprotein (LDL) values &lt;1.4 mmol\/L by 1 year. In conclusion, there were no major differences by HIV status in the treatment and outcomes of ACS in 1-year follow-up, but the results indicate that secondary prevention should be enhanced.<\/jats:p>","DOI":"10.1177\/10872914261473689","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:10:46Z","timestamp":1785913846000},"page":"381-390","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment and Outcomes After Acute Coronary Syndrome in People with HIV Compared to People without HIV in Finland 2017\u20132024"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-6812","authenticated-orcid":false,"given":"Mikaela","family":"Mutru","sequence":"first","affiliation":[{"name":"Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland."},{"name":"HUS Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Kivel\u00e4","sequence":"additional","affiliation":[{"name":"Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland."},{"name":"HUS Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Ollgren","sequence":"additional","affiliation":[{"name":"Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmi","family":"Liukko","sequence":"additional","affiliation":[{"name":"Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Eastern Finland, Kuopio, Finland."},{"name":"Heart Center, Kuopio University Hospital, Kuopio, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Porela","sequence":"additional","affiliation":[{"name":"Heart Center, Turku University Hospital and University of Turku, Turku, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Hannila-Handelberg","sequence":"additional","affiliation":[{"name":"Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Aho","sequence":"additional","affiliation":[{"name":"Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland."},{"name":"HUS Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.033369"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7954"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.11159"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000695"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13009"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/10872914251359817"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ013"},{"key":"e_1_3_3_9_1","unstructured":"8.Digital and Population Data Services Agency. Personal identity code. Digi- ja v\u00e4est\u00f6tietovirasto. Available from: https:\/\/dvv.fi\/en\/personal-identity-code2 [Last accessed: December5 2025]."},{"issue":"3","key":"e_1_3_3_10_1","first-page":"106","article-title":"Sepelvaltimotaudin kansallinen laaturekisteri: Syd\u00e4nrekisterin ensimm\u00e4inen osa [National register for coronary artery disease: First part of Cardiac register]","volume":"32","author":"Eskola M","year":"2022","unstructured":"9.Eskola M, , Mustonen P, , Porela P, et al. Sepelvaltimotaudin kansallinen laaturekisteri: Syd\u00e4nrekisterin ensimm\u00e4inen osa [National register for coronary artery disease: First part of Cardiac register]. Erikoisl\u00e4\u00e4k\u00e4ri 2022;32(3):106\u2013108.","journal-title":"Erikoisl\u00e4\u00e4k\u00e4ri"},{"issue":"2","key":"e_1_3_3_11_1","first-page":"255","article-title":"Sepelvaltimotaudin kansallinen laaturekisteri\u2014vihdoin Suomeenkin! [National register for coronary artery disease\u2014finally to Finland!]","volume":"31","author":"Hartikainen J","year":"2020","unstructured":"10.Hartikainen J, , Eskola M, , Mustonen P. Sepelvaltimotaudin kansallinen laaturekisteri\u2014vihdoin Suomeenkin! [National register for coronary artery disease\u2014finally to Finland!]. Syd\u00e4n\u00e4\u00e4ni 2020;31(2A):255\u2013260.","journal-title":"Syd\u00e4n\u00e4\u00e4ni"},{"key":"e_1_3_3_12_1","unstructured":"11.Finnish Institute for Health and Welfare. Register Description: Care Register for Health Care. THL; 2023. Available from: https:\/\/thl.fi\/en\/statistics-and-data\/data-and-services\/register-descriptions\/care-register-for-health-care [Last accessed: December5 2025]."},{"key":"e_1_3_3_13_1","unstructured":"12.Finnish Institute for Health and Welfare. Cardiac register (national quality register). THL; 2024. Available from: https:\/\/thl.fi\/en\/statistics-and-data\/data-and-services\/register-descriptions\/cardiac-register-national-quality-register-1 [Last accessed: December5 2025]."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053287"},{"key":"e_1_3_3_15_1","unstructured":"14.Finnish Institute for Health and Welfare. HIV register (national quality register). THL; 2024. Available from: https:\/\/thl.fi\/en\/statistics-and-data\/data-and-services\/register-descriptions\/hiv-register-national-quality-register-15 [Last accessed: December5 2025]."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14744"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaa088"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2017.0128"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05416-6"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009849"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw082"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-015-0045-z"},{"issue":"10","key":"e_1_3_3_24_1","first-page":"403","article-title":"Influence of human immunodeficiency virus seropositive status on the in-hospital management and outcomes of patients presenting with acute myocardial infarction","volume":"28","author":"Smilowitz NR","year":"2016","unstructured":"23.Smilowitz NR, , Gupta N, , Guo Y, et al. Influence of human immunodeficiency virus seropositive status on the in-hospital management and outcomes of patients presenting with acute myocardial infarction. J Invasive Cardiol 2016;28(10):403\u2013409.","journal-title":"J Invasive Cardiol"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12670"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001874"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.02.017"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq372"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad415"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00319-2"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00089-2"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304146"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120479"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(25)00047-5"},{"key":"e_1_3_3_35_1","unstructured":"34.Waters L Gilleece Y Alagaratnam J et al. BHIVA rapid guidance on the use of statins for primary prevention of cardiovascular disease in people living with HIV v2. 2025. Available from: https:\/\/bhiva.org\/rapid-guidance\/bhiva-rapid-guidance-on-the-use-of-statins-for-primary-prevention-of-cardiovascular-disease\/. [Last accessed: December7 2025]."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-03564"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.10.013"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2022.03.006"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13150"},{"key":"e_1_3_3_41_1","unstructured":"40.Finnish Institute for Health and Welfare. Syd\u00e4nrekisterin raportti [Cardiac Register Report]. 2025. Available from: https:\/\/www.thl.fi\/kansallisten-laaturekisterien-raportit\/sydanrekisteri\/sydanrekisteri_kokosuomi.html [Last accessed: December8 2025]."},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"e_1_3_3_43_1","first-page":"2653","article-title":"Working group set up by the finnish medical society duodecim and the finnish cardiac society. dyslipidemia. Current Care Guidelines Update","volume":"136","year":"2020","unstructured":"42.Working group set up by the finnish medical society duodecim and the finnish cardiac society. dyslipidemia. Current Care Guidelines Update. Duodecim 2020;136:2653\u20132654.","journal-title":"Duodecim"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1711"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae576"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030414"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvac064"},{"key":"e_1_3_3_50_1","unstructured":"49.Kela. [Social Insurance Institution]. Kansanel\u00e4kelaitoksen p\u00e4\u00e4t\u00f6s tarvittavista selvityksist\u00e4 ja l\u00e4\u00e4ketieteellisist\u00e4 edellytyksist\u00e4 joiden tulee rajoitetusti erityiskorvattavan l\u00e4\u00e4kkeen korvaamiseksi t\u00e4ytty\u00e4 [Social Insurance Institution on criteria for limited special reimbursement of medication]. Kela; 2021."},{"key":"e_1_3_3_51_1","unstructured":"50.Kela [Social Insurance Institution]. Evolokumabin LDL-kolesterolipitoisuuden raja-arvo alenee valtimosairauksiin liittyvien rasva-aineenvaihdunnan h\u00e4iri\u00f6iden hoidossa 1.1.2024 alkaen [LDL value criteria for evolokumab decreases on 1.1.2024 in treatment of dyslipidemia linked to atherosclerotic arterial diseases]. Kela; 2023. Available from: https:\/\/www.kela.fi\/ajankohtaista\/evolokumabi-1.1.2024-alkaen [Last accessed: December8 2025]."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjr.0000239466.26132.f2"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00149831-200504000-00007"},{"issue":"33","key":"e_1_3_3_54_1","first-page":"1953","article-title":"Sepelvaltimotaudin kajoavia toimenpiteit\u00e4 koskevien rekisteritietojen luotettavuus ja kehityssuunnat 1994\u20132011 [Validity and development of register data on invasive procedures for coronary artery disease 1994 to 2011]","volume":"69","author":"M\u00e4h\u00f6nen M","year":"2014","unstructured":"53.M\u00e4h\u00f6nen M, , Pietil\u00e4 A, , Havulinna AS, et al. Sepelvaltimotaudin kajoavia toimenpiteit\u00e4 koskevien rekisteritietojen luotettavuus ja kehityssuunnat 1994\u20132011 [Validity and development of register data on invasive procedures for coronary artery disease 1994 to 2011]. Suom L\u00e4\u00e4k\u00e4rilehti 2014;69(33):1953\u20131958.","journal-title":"Suom L\u00e4\u00e4k\u00e4rilehti"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494819847051"},{"key":"e_1_3_3_56_1","unstructured":"55.Finnish Institute for Health and Welfare. Tartuntataudit Suomessa 2023 [Communicable Diseases in Finland]. 2024. Available from: https:\/\/www.julkari.fi\/handle\/10024\/149681"},{"key":"e_1_3_3_57_1","unstructured":"56.Metso S Tahkola A Vanham\u00e4ki S et al. Ty\u00f6paperi 11\/2022. Valtava-hanke\u2014Diabetesrekisterin p\u00e4\u00e4raportti [Working paper 11\/2022. Valtava-project\u2014Main report of Diabetes Register]. 2022. Available from: http:\/\/urn.fi\/URN:ISBN:978-952-343-846-0"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70920"}],"container-title":["AIDS Patient Care and STDs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10872914261473689","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10872914261473689","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10872914261473689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:16:14Z","timestamp":1788477374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10872914261473689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10.1177\/10872914261473689"],"URL":"https:\/\/doi.org\/10.1177\/10872914261473689","relation":{},"ISSN":["1087-2914","1557-7449"],"issn-type":[{"value":"1087-2914","type":"print"},{"value":"1557-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}